Correlation Between Bristol Myers and Bayer AG
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Bayer AG at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Bayer AG into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Bayer AG, you can compare the effects of market volatilities on Bristol Myers and Bayer AG and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Bayer AG. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Bayer AG.
Diversification Opportunities for Bristol Myers and Bayer AG
-0.84 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Bristol and Bayer is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Bayer AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bayer AG and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Bayer AG. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bayer AG has no effect on the direction of Bristol Myers i.e., Bristol Myers and Bayer AG go up and down completely randomly.
Pair Corralation between Bristol Myers and Bayer AG
Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.85 times more return on investment than Bayer AG. However, Bristol Myers Squibb is 1.18 times less risky than Bayer AG. It trades about 0.2 of its potential returns per unit of risk. Bayer AG is currently generating about -0.37 per unit of risk. If you would invest 5,250 in Bristol Myers Squibb on August 30, 2024 and sell it today you would earn a total of 677.00 from holding Bristol Myers Squibb or generate 12.9% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bristol Myers Squibb vs. Bayer AG
Performance |
| Timeline |
| Bristol Myers Squibb |
| Bayer AG |
Bristol Myers and Bayer AG Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bristol Myers and Bayer AG
The main advantage of trading using opposite Bristol Myers and Bayer AG positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Bayer AG can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bayer AG will offset losses from the drop in Bayer AG's long position.| Bristol Myers vs. Emergent Biosolutions | Bristol Myers vs. Bausch Health Companies | Bristol Myers vs. Neurocrine Biosciences | Bristol Myers vs. Teva Pharma Industries |
| Bayer AG vs. Playstudios | Bayer AG vs. Space Communication | Bayer AG vs. Nextplat Corp | Bayer AG vs. Evolution Gaming Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |